Rosenberg Matthew Hamilton Novartis Ag Transaction History
Rosenberg Matthew Hamilton
- $426 Million
- Q2 2025
A detailed history of Rosenberg Matthew Hamilton transactions in Novartis Ag stock. As of the latest transaction made, Rosenberg Matthew Hamilton holds 1,307 shares of NVS stock, worth $153,873. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,307
Previous 1,307
-0.0%
Holding current value
$153,873
Previous $145,000
8.97%
% of portfolio
0.04%
Previous 0.04%
Shares
17 transactions
Others Institutions Holding NVS
# of Institutions
1,554Shares Held
142MCall Options Held
1.64MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.39 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.22 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$1.01 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$831 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$796 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $253B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...